New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…
Read More »safety
New Delhi: A new weapon against the debilitating infection of Chikungunya could soon be in the offing. A multi-country Phase…
Read More »New Delhi (India Science Wire): The operation guidelines prepared by the Central Government for the COVID-19 vaccination programme currently underway,…
Read More »New Delhi (India Science Wire): Considering that the highest level of political and administrative ownership, commitment, and support are needed…
Read More »